Trade name: Clavucill 200 mg/50 mg
Active substance: acid clavulanic, amoxicilină trihidrat
Therapeutic group: Antibiotics
Pharmaceutical form: comprimate
Presentation: Blister x 10 cpr. Cutii x 10, 100, 250 cpr.
Trade name: Clavucill 200 mg/50 mg
Active substance: acid clavulanic, amoxicilină trihidrat
Therapeutic group: Antibiotics
Pharmaceutical form: comprimate
Presentation: Blister x 10 cpr. Cutii x 10, 100, 250 cpr.
Target species: dogs
Therapeutic action: Caini Tratamentul infectiilor cauzate de microorganisme sensibile la combinatia amoxicilina si acid clavulanic, in special: dermatite cauzate de Staphylococcus intermedius, infectii ale tractului urinar cauzate de E. coli, infectii ale tractului respirator cauzate de Streptococus spp., enterita cauzată de E. coli.
Waiting period: Nu este cazul.
Release mode: Cu prescripţie
Authorization number: 160254
Authorization status: Valida
Date of issue of the authorization: 16-08-2016
Authorization valid until: nelimitata
Manufacturer / Serial Release Company: V.M.D., Belgia
Licensee: V.M.D., Belgia
Remarks: Autorizat prin MRP.